APA (7th ed.) Citation

Poniman, M., Imzourh, A., Bened, H., Chemouni, D., Corral, R., Bastide, C., . . . Long Depaquit, T. (2026). Clinical significance of MRI PI-RADS 3 lesions upgraded by dynamic contrast enhancement: The “PI-RADS 3 + 1” subgroup. International Urology and Nephrology, 1. https://doi.org/10.1007/s11255-026-05265-3

Chicago Style (17th ed.) Citation

Poniman, Margaux, Assia Imzourh, Hector Bened, David Chemouni, Renaud Corral, Cyrille Bastide, Michael Baboudjian, and Thibaut Long Depaquit. "Clinical Significance of MRI PI-RADS 3 Lesions Upgraded by Dynamic Contrast Enhancement: The “PI-RADS 3 + 1” Subgroup." International Urology and Nephrology 2026: 1. https://doi.org/10.1007/s11255-026-05265-3.

MLA (9th ed.) Citation

Poniman, Margaux, et al. "Clinical Significance of MRI PI-RADS 3 Lesions Upgraded by Dynamic Contrast Enhancement: The “PI-RADS 3 + 1” Subgroup." International Urology and Nephrology, 2026, p. 1, https://doi.org/10.1007/s11255-026-05265-3.